Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference33 articles.
1. Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: role of GLP-1 and GLP-1 receptor;Abd El Motteleb;Eur. J. Pharmacol.,2013
2. The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications;Avogaro;Diabetes Care,2014
3. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes;Burnier;J. Hypertens.,2006
4. Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes;Deacon;Adv. Ther,2009
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group;Diabetes Control and Complications Trial Research Group;N. Engl. J. Med.,1993
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dipeptidyl Peptidase-4 (DPP4) Inhibitors;Diabetes and Kidney Disease;2022
2. Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells;Pharmacological Research;2021-07
3. DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice;American Journal of Physiology-Renal Physiology;2021-03-01
4. Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases;Pharmacological Research;2020-09
5. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways;European Journal of Pharmacology;2019-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3